<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A large proportion of <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>) display mutational inactivation of the TGF-β pathway, yet, paradoxically, they are characterized by elevated TGF-β production </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we unveil a prometastatic program induced by TGF-β in the microenvironment that associates with a high risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> relapse upon treatment </plain></SENT>
<SENT sid="2" pm="."><plain>The activity of TGF-β on stromal cells increases the efficiency of organ colonization by <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells, whereas mice treated with a pharmacological inhibitor of TGFBR1 are resilient to <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> formation </plain></SENT>
<SENT sid="3" pm="."><plain>Secretion of IL11 by TGF-β-stimulated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-associated fibroblasts (CAFs) triggers GP130/STAT3 signaling in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="4" pm="."><plain>This crosstalk confers a survival advantage to metastatic cells </plain></SENT>
<SENT sid="5" pm="."><plain>The dependency on the TGF-β stromal program for <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> initiation could be exploited to improve the diagnosis and treatment of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>